Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Internal Medicine

Background:

• Dilated cardiomyopathy (DCM) is a primary heart muscle disease affecting younger patients with few comorbidities.
• It involves structural/functional abnormalities leading to ventricular systolic dysfunction and dilatation.
• Exclusion of ischemic, valvular, or pressure overload causes is key to diagnosis.

Purpose of the Study:

• To highlight the importance of prognostic stratification in DCM, particularly for predicting arrhythmic events.
• To emphasize the need for comprehensive diagnostic work-up and aetiopathogenetic characterization for improved patient outcomes.
• To illustrate a multiparametric approach for accurate arrhythmic risk stratification.

Main Methods:

• Integration of medical history and physical examination.
• Utilization of advanced cardiac imaging techniques.
• Inclusion of genetic testing for aetiological characterization.
• Repeated evaluations to track disease progression and risk changes.

Main Results:

• A multiparametric approach enhances diagnostic accuracy for DCM.
• Comprehensive characterization aids in personalized diagnosis and therapeutic strategies.
• Accurate risk stratification, especially for arrhythmias, is achievable through integrated methods.

Conclusions:

• An exhaustive aetiological and clinical-instrumental characterization is essential for tailored DCM diagnosis.
• Multiparametric evaluation, including genetic testing, is crucial for precise arrhythmic risk stratification.
• Regular reassessment of dynamic pathology trends and risk changes optimizes patient management.